Project backed by £9.1m funding from ARIA, the Advanced Research + Invention Agency, to develop synthetic chloroplast genomes Project is led by the Max-Planck Institute of Molecular Plant Physiology and also includes academics from University of Essex and UC Berkeley Cambridge, UK – Camena Bioscience (Camena), an innovator in enzymatic DNA synthesis, and Constructive Bio (Constructive), a pioneer […]

Designation for BioFlyte’s aerosol chem/biothreat detection and identification technology underscores proven performance, customer protections, and competitive differentiation in homeland security market ALBUQUERQUE, N.M. — BioFlyte, a chemical and bioaerosol surveillance firm with a disruptive new class of fieldable chemical and biological threat collection, detection, and identification solutions, today announced that the U.S. Department of Homeland […]

Center of Excellence will feature bio-environmental research to facilitate advancements in environmental health and safety SANTA CLARA, Calif. & ATLANTA — Agilent Technologies Inc. and Georgia Tech today announced the establishment of an Agilent Center of Excellence (CoE) for Environmental Health and Engineering to advance research in environmental sustainability, water recycling, and biologics. Internationally recognized environmental scientist Professor Shane […]

Believes Years of Self-Inflicted Issues Have Caused Avantor to Trade at a Meaningful Discount to its Intrinsic Value and Life Sciences Peers Contends the Board Has Failed to Remedy Operating Underperformance, Ineffective Cost Controls and Poor Capital Deployment – Resulting in Significant Value Destruction Over Every Relevant Period Makes Clear the Board Needs to Be […]

Emmanuel Ligner, Seasoned Leader with Proven Track Record of Value Creation in Life Sciences, to Begin Role as CEO Next Week RADNOR, Pa. — Avantor, Inc. (NYSE: AVTR), a leading global provider of mission-critical products and services to customers in the life sciences and advanced technology industries, today issued the following statement in response to the […]

nvestment in premises on Cambridge Technopark reflects significant milestone in the Company’s growth Relocation increases logistics and R&D capacity, enabling faster customization and turnaround, strengthening order fulfilment to better support customers in their research and development efforts Cambridge, UK: Antibodies.com, a trusted provider of high-quality biological reagents for life science researchers, today announced the expansion […]

MINNEAPOLIS — Bio-Techne Corporation (NASDAQ: TECH) today announced an agreement where Mdxhealth SA will acquire its Exosome Diagnostics Inc. business, including the ExoDx Prostate (EPI) test, CLIA-certified clinical laboratory and related assets. Bio-Techne will retain access to the proprietary exosome-based technology for ongoing kit development in its precision diagnostics growth pillar. “Mdxhealth is the ideal […]

ST. PAUL, Minn. — ScaleReady, in collaboration with Wilson Wolf Manufacturing, Bio-Techne Corporation and CellReady, today announced that Sidra Medicine, a women and children’s hospital in Qatar, has been awarded a $100,000 G-Rex® Grant. Sidra Medicine’s G-Rex® Grant will enable expeditious development, validation, and implementation of a G-Rex® centric CAR-T cell production platform. The G-Rex Grant […]

MaxCyte’s Flow Electroporation® technology and ExPERT™ platform to support development of Adicet’s gamma delta T cell therapy gene edited programs ROCKVILLE, Md — MaxCyte, Inc., (Nasdaq: MXCT), a leading, cell-engineering focused company providing enabling platform technologies to advance the discovery, development and commercialization of next-generation cell-based therapeutics, today announced it has signed a strategic platform license […]

ST. PAUL, Minn. — ScaleReady, in collaboration with Wilson Wolf Manufacturing, Bio-Techne Corporation (NASDAQ: TECH) and CellReady, today announced that three investigators at the University of Minnesota’s Center for Genome Engineering have been awarded $665,000 of G-Rex® Grant funding. Dr. Branden Moriarity, Associate Professor at the University of Minnesota, Co-Director of Center for Genome Engineering, Co-Director […]